Applied DNA Sciences (APDN) Misses Q1 EPS by 36c

Applied DNA Sciences (NASDAQ: APDN) reported Q1 EPS of ($0.63), $0.36 worse than the analyst estimate of ($0.27). Revenue for the quarter came in at $4.2 million versus the consensus estimate of $4.02 million.

For earnings history and earnings-related data on Applied DNA Sciences (APDN) click here.

You May Also Be Interested In

• Oracle (ORCL) Tops Q1 EPS by 19c, Beats on Revenue; Beats on Cloud Revenue, Offers Q3 EPS Guidance
• UBS Downgrades Ypsomed Holding AG (YPSN:SW) to Neutral
• Oracle raises full year profit guidance, stock rises after hours